CONCORD BIOTECH   
                    
                    
                                                         
                                
                                                                 Back to All Ratios 
                                                
                     | 
                        
                        
                        
                        
                    
CONCORD BIOTECH Last 5 Year EV/Core EBITDA History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EV/Core EBITDA(x) | 31.81 | 34.08 | - | -0.06 | 0.10 | 
What is the latest EV/Core EBITDA ratio of CONCORD BIOTECH ?
| Year | EV/Core EBITDA | 
|---|---|
| Mar2025 | 31.81 | 
| Mar2024 | 34.08 | 
| Mar2023 | - | 
| Mar2022 | -0.06 | 
| Mar2021 | 0.10 | 
How is EV/Core EBITDA of CONCORD BIOTECH Trending?
| Years | EV/Core EBITDA | % Change | |
|---|---|---|---|
| Mar2025 | 31.81 | -6.66 | |
| Mar2024 | 34.08 | 0 | |
| Mar2023 | 0 | 100.00 | |
| Mar2022 | -0.06 | Negative | |
| Mar2021 | 0.1 | - | |
Other Financial Ratios of CONCORD BIOTECH
| Operational &  Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate  | Margin  Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin  | Performance  Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales  | Efficiency  Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days  | Valuation  Parameters PER PCE Price/Book Yield EV/Net Sales EV/EBIT EV/CE M Cap / Sales  | Growth  Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth  | Financial Stability  Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap  | 
Compare EV/Core EBITDA ratio of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹15,356.8 Cr | 2.5% | -10.1% | -20.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,626.0 Cr | 1.2% | 4.4% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,669.0 Cr | 5.8% | 19.2% | 16.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹122,793.0 Cr | 1.4% | 1.8% | 10.8% | Stock Analytics | |
| CIPLA | ₹122,103.0 Cr | -3.7% | -0.2% | 1.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,857.4 Cr | -7.3% | -4% | -6.1% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| CONCORD BIOTECH |    2.5%  | 
                            
                     
                     -10.1%  | 
                     
                     -20.7%  | 
                    
| SENSEX |    -0.9%  |    
                      
                    
                     4.6%  | 
                     
                     5%  | 
                    
You may also like the below Video Courses